Amgen (AMGN) Invested Capital (2009 - 2026)
Amgen's quarterly Invested Capital came in at $66.5 billion in Q1 2026, up 4.6% year-on-year from $63.6 billion in Q1 2025, and up 5.14% quarter-over-quarter from $63.3 billion in Q4 2025.
Amgen has reported Invested Capital for 18 years, with the latest figure at $66.5 billion in Q1 2026.
- For the quarter ending Q1 2026, Invested Capital rose 4.6% year-over-year to $66.5 billion; the trailing twelve-month figure through Mar 2026 stood at $66.5 billion (up 4.6% YoY), and the FY2025 full-year result was $63.3 billion, down 4.11% from the prior year.
- Invested Capital for Q1 2026 stood at $66.5 billion, up from $63.3 billion in the prior quarter.
- The five-year high for Invested Capital was $70.8 billion in Q4 2023, with the low at $37.8 billion in Q1 2022.
- Average Invested Capital over 5 years is $60.5 billion, with a median of $66.0 billion recorded in 2024.
- Year-over-year, Invested Capital decreased 10.03% in 2022 and surged 77.04% in 2023.
- Tracing AMGN's Invested Capital over 5 years: stood at $42.6 billion in 2022, then surged by 66.46% to $70.8 billion in 2023, then slipped by 6.87% to $66.0 billion in 2024, then slipped by 4.11% to $63.3 billion in 2025, then gained by 5.14% to $66.5 billion in 2026.
- The last three Invested Capital figures came in at $66.5 billion (Q1 2026), $63.3 billion (Q4 2025), and $64.2 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 72.79 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 98.65 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | -6.66 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 48.32 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 66.51 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 45.69 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 90.96 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 64.21 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | 71.36 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 66.51 Bn |
| Dec 31, 2025 | 63.26 Bn |
| Sep 30, 2025 | 64.21 Bn |
| Jun 30, 2025 | 63.63 Bn |
| Mar 31, 2025 | 63.59 Bn |
| Dec 31, 2024 | 65.98 Bn |
| Sep 30, 2024 | 67.93 Bn |
| Jun 30, 2024 | 68.53 Bn |
| Mar 31, 2024 | 69.04 Bn |
| Dec 31, 2023 | 70.85 Bn |
| Sep 30, 2023 | 68.16 Bn |
| Jun 30, 2023 | 68.28 Bn |
| Mar 31, 2023 | 66.95 Bn |
| Dec 31, 2022 | 42.56 Bn |
| Sep 30, 2022 | 42.35 Bn |
| Jun 30, 2022 | 38.94 Bn |
| Mar 31, 2022 | 37.82 Bn |
| Dec 31, 2021 | 40.01 Bn |
| Sep 30, 2021 | 45.82 Bn |
| Jun 30, 2021 | 41.05 Bn |
| Mar 31, 2021 | 42.03 Bn |
| Dec 31, 2020 | 42.41 Bn |
| Sep 30, 2020 | 45.26 Bn |
| Jun 30, 2020 | 44.86 Bn |
| Mar 31, 2020 | 41.29 Bn |
| Dec 31, 2019 | 39.58 Bn |
| Sep 30, 2019 | 40.73 Bn |
| Jun 30, 2019 | 41.39 Bn |
| Mar 31, 2019 | 43.86 Bn |
| Dec 31, 2018 | 46.43 Bn |
| Sep 30, 2018 | 48.78 Bn |
| Jun 30, 2018 | 49.41 Bn |
| Mar 31, 2018 | 51.16 Bn |
| Dec 31, 2017 | 60.58 Bn |
| Sep 30, 2017 | 68.01 Bn |
| Jun 30, 2017 | 35.16 Bn |
| Mar 31, 2017 | 33.74 Bn |
| Dec 31, 2016 | 64.47 Bn |
| Sep 30, 2016 | 66.10 Bn |
| Jun 30, 2016 | 33.48 Bn |
| Mar 31, 2016 | 34.42 Bn |
| Dec 31, 2015 | 59.48 Bn |
| Sep 30, 2015 | 59.73 Bn |
| Jun 30, 2015 | 59.44 Bn |
| Mar 31, 2015 | 56.85 Bn |
| Dec 31, 2014 | 56.49 Bn |
| Sep 30, 2014 | 58.31 Bn |
| Jun 30, 2014 | 57.71 Bn |
| Mar 31, 2014 | 22.74 Bn |
| Dec 31, 2013 | 54.22 Bn |
| Sep 30, 2013 | 21.73 Bn |
| Jun 30, 2013 | 20.59 Bn |
| Mar 31, 2013 | 19.49 Bn |
| Dec 31, 2012 | 19.06 Bn |
| Sep 30, 2012 | 19.90 Bn |
| Dec 31, 2011 | 19.03 Bn |
| Sep 30, 2011 | 37.52 Bn |
| Jun 30, 2011 | 39.54 Bn |
| Mar 31, 2011 | 35.89 Bn |
| Dec 31, 2010 | 37.31 Bn |
| Sep 30, 2010 | 37.36 Bn |
| Jun 30, 2010 | 34.90 Bn |
| Mar 31, 2010 | 24.72 Bn |
| Dec 31, 2009 | 33.27 Bn |
| Sep 30, 2009 | 22.86 Bn |
| Jun 30, 2009 | 21.36 Bn |